Tenaya Therapeutics, Inc. (TNYA)
NASDAQ$0.73+0.03 (4.29%)
Market Cap
$113.63M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
8 of 924
Rank in Industry
7 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
TNYA Insider Trading Activity
TNYA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $49,999,998 | 2 | 22 |
Sells | $71,907 | 7 | 78 |
Related Transactions
| COLUMN GROUP III GP, LP | 10 percent owner | 1 | $25M | 0 | $0 | $25M |
| GOEDDEL DAVID V | 1 | $25M | 0 | $0 | $25M | |
| Higa Tomohiro | SVP, Finance | 0 | $0 | 1 | $1,336 | $-1,336 |
| Saito Chihiro | SVP, Accounting and Fin. Ops. | 0 | $0 | 2 | $11,627 | $-11,627 |
| Tingley Whittemore | Chief Medical Officer | 0 | $0 | 2 | $25,483 | $-25,483 |
| Ali Faraz | Chief Executive Officer | 0 | $0 | 2 | $33,460 | $-33,460 |
About Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart …
Insider Activity of Tenaya Therapeutics, Inc.
Over the last 12 months, insiders at Tenaya Therapeutics, Inc. have bought $50M and sold $71,907 worth of Tenaya Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Tenaya Therapeutics, Inc. have bought $40.42M and sold $127,497 worth of stock each year.
Highest buying activity among insiders over the last 12 months: COLUMN GROUP III GP, LP (10 percent owner) — $25M. GOEDDEL DAVID V () — $25M.
The last purchase of 35,714,284 shares for transaction amount of $25M was made by GOEDDEL DAVID V () on 2025‑03‑05.
List of Insider Buy and Sell Transactions, Tenaya Therapeutics, Inc.
| 2025-03-10 | Sale | Ali Faraz | Chief Executive Officer | 9,741 0.0067% | $0.54 | $5,245 | +25.62% | |
| 2025-03-10 | Sale | Tingley Whittemore | Chief Medical Officer | 7,398 0.0051% | $0.54 | $3,983 | +25.62% | |
| 2025-03-10 | Sale | Higa Tomohiro | SVP, Finance | 2,482 0.0017% | $0.54 | $1,336 | +25.62% | |
| 2025-03-05 | GOEDDEL DAVID V | 35.71M 63.7654% | $0.70 | $25M | +18.73% | |||
| 2025-03-05 | COLUMN GROUP III GP, LP | 10 percent owner | 35.71M 63.7654% | $0.70 | $25M | +18.73% | ||
| 2024-11-18 | Sale | Saito Chihiro | SVP, Accounting and Fin. Ops. | 2,258 0.0029% | $2.12 | $4,787 | -34.71% | |
| 2024-08-16 | Sale | Ali Faraz | Chief Executive Officer | 9,748 0.0131% | $2.89 | $28,216 | -35.29% | |
| 2024-08-16 | Sale | Tingley Whittemore | Chief Medical Officer | 7,428 0.01% | $2.89 | $21,500 | -35.29% | |
| 2024-08-16 | Sale | Saito Chihiro | SVP, Accounting and Fin. Ops. | 2,363 0.0032% | $2.89 | $6,840 | -35.29% | |
| 2024-03-05 | Sale | Hoey Timothy | Chief Scientific Officer | 3,300 0.0044% | $7.00 | $23,101 | -58.82% | |
| 2024-02-20 | Sale | Hoey Timothy | Chief Scientific Officer | 6,569 0.0087% | $5.34 | $35,046 | -44.47% | |
| 2024-02-16 | Sale | Hoey Timothy | Chief Scientific Officer | 4,681 0.0064% | $5.86 | $27,431 | -53.48% | |
| 2024-02-16 | Sale | Ali Faraz | Chief Executive Officer | 6,358 0.0087% | $5.86 | $37,258 | -53.48% | |
| 2024-02-16 | Sale | Tingley Whittemore | Chief Medical Officer | 6,500 0.0088% | $5.86 | $38,090 | -53.48% | |
| 2024-02-16 | Sale | PATTERSON LEONE D | Chief Fin. and Bus. Officer | 5,201 0.0071% | $5.86 | $30,478 | -53.48% | |
| 2024-02-12 | GOEDDEL DAVID V | 2.22M 2.6767% | $4.50 | $10M | -47.35% | |||
| 2024-02-12 | COLUMN GROUP III GP, LP | 10 percent owner | 2.22M 2.6767% | $4.50 | $10M | -47.35% | ||
| 2023-08-29 | Sale | Hoey Timothy | Chief Scientific Officer | 7,243 0.0111% | $4.26 | $30,855 | -18.28% | |
| 2023-08-16 | Sale | Hoey Timothy | Chief Scientific Officer | 4,007 0.0059% | $3.81 | $15,267 | -8.72% | |
| 2023-08-16 | Sale | Ali Faraz | Chief Executive Officer | 5,563 0.0083% | $3.81 | $21,195 | -8.72% |
Total: 39
*Gray background shows transactions not older than one year
Insider Historical Profitability
13.51%
| GOEDDEL DAVID V | 49313559 30.3314% | $34.47M | 8 | 0 | +17.53% | |
| COLUMN GROUP III GP, LP | 10 percent owner | 49313559 30.3314% | $34.47M | 8 | 0 | +17.53% |
| Casdin Eli | director | 6078860 3.7389% | $4.25M | 2 | 0 | <0.0001% |
| Casdin Partners Master Fund, L.P. | 10 percent owner | 3224849 1.9835% | $2.25M | 1 | 0 | <0.0001% |
| Srivastava Deepak | director | 372435 0.2291% | $260,294.82 | 1 | 0 | +31.33% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$12,784,645 | 193 | 20.49% | $111.89M | |
$22,597,521 | 91 | 4.59% | $104.68M | |
$54,751,750 | 62 | -1.03% | $118.75M | |
$16,245,616 | 40 | 123.58% | $122.63M | |
$36,079,815 | 31 | 43.23% | $103.59M |
TNYA Institutional Investors: Active Positions
| Increased Positions | 47 | +41.23% | 9M | +16.24% |
| Decreased Positions | 48 | -42.11% | 22M | -38.52% |
| New Positions | 17 | New | 504,660 | New |
| Sold Out Positions | 30 | Sold Out | 15M | Sold Out |
| Total Postitions | 113 | -0.88% | 44M | -22.28% |
TNYA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Column Group Llc | $6,571.00 | 5.77% | 9.4M | 0 | 0% | 2024-12-31 |
| Casdin Capital, Llc | $4,706.00 | 4.13% | 6.73M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $3,702.00 | 3.25% | 5.3M | +1M | +28.98% | 2024-12-31 |
| Jpmorgan Chase & Co | $3,604.00 | 3.16% | 5.16M | +5M | +20,670.27% | 2024-12-31 |
| Vanguard Group Inc | $2,287.00 | 2.01% | 3.27M | +58,877 | +1.83% | 2024-12-31 |
| Vr Adviser, Llc | $1,087.00 | 0.95% | 1.56M | 0 | 0% | 2024-12-31 |
| Ghost Tree Capital, Llc | $1,049.00 | 0.92% | 1.5M | +150,000 | +11.11% | 2024-09-30 |
| Morgan Stanley | $1,040.00 | 0.91% | 1.49M | +1M | +375.51% | 2024-12-31 |
| Geode Capital Management, Llc | $887.00 | 0.78% | 1.27M | -27,419 | -2.12% | 2024-12-31 |
| State Street Corp | $771.00 | 0.68% | 1.1M | +44,194 | +4.17% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.